Search - tctmd.com

Displaying 1 - 20 of 76

Sort: Relevancy | Date

INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen Over Time

News Conference News TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Michael O'Riordan

October 29, 2025

Presentation TCT 2025

TCT 400: Mortality Trends in Acute Myocardial Infarction With Chronic Ischemic Heart Disease: CDC WONDER Data Analysis, 1999–2020

Presenter: Hriday Shah

October 27, 2025

Presentation TCT 2025

TCT 296: 25-Year Trends in Postoperative Mortality in U.S. Adults with Ischemic Heart Disease

Presenter: Zeyad Kholeif

October 27, 2025

Presentation TCT 2025

TCT 573: The Impact of Hypertension on the Burden of Ischemic Heart Disease in the United States: Temporal Analysis of the Past 3 Decades

Presenter: Zaid Ali Abdulelah

October 27, 2025

Presentation TCT 2025

TCT 792: First-in-human experience with a novel self-expandable coronary sinus reducer for treating symptomatic epicardial and microvascular ischemic heart disease

Presenter: Francesco Giannini

October 26, 2025

News Conference News TCT 2025

TTVR Remains Safe, Effective in Presence of CIED Leads

Todd Neale

October 25, 2025

News Conference News TCT 2024

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Yael L. Maxwell

November 05, 2024

News Conference News TCT 2024

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

Todd Neale

October 31, 2024

Presentation TCT 2024

TCT 102: First-in-Man Experience With the Self-Expandable A-Flux Coronary Sinus Reducer for Treating Symptomatic Ischemic Heart Disease

Presenter: Francesco Giannini

October 30, 2024

Presentation TCT 2024

The Transformation of Diagnosis and Risk Profiling for Ischemic Heart disease: An AI Case Study

Presenter: James Min

October 30, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

TCT 250: Temporal Trends in Ischemic Heart Disease-related Mortality in Canada Over the Past 3 Decades

Presenter: Ahmed Abdulelah

October 29, 2024

Presentation TCT 2024

Final Results of the Novel Healing-Targeted DES With Synchronized Antiproliferative Drug Delivery to Target Smooth Muscle Cell Proliferation After DES Implantation in Coronary Artery Disease: 5-Year Results of the PIONEER III Trial

Presenter: Thomas Sharp

October 28, 2024

News Conference News TCT 2023

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Yael L. Maxwell

November 06, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

Presentation TCT 2023

TCT 615: Incorporation of Automated Robotic Transcranial Doppler to Screen for PFO and Quantify Right to Left Shunt Severity in the Evaluation of Ischemic Stroke Patients for Stroke Etiology at a Comprehensive Stroke Center

Presenter: Ira Chang

October 24, 2023

Presentation TCT 2022

TCT 329: Cerebral Embolic Protection Devices For Prevention Of Post-Procedural Ischemic Stroke With Transcatheter Aortic Valve Replacement: A SYSTEMATIC REVIEW AND META-ANALYSIS

Presenter: Tanesh Ayyalu

September 18, 2022

Presentation TCT 2022

Case #3: Symptomatic Microvascular Disease

Presenter: Nils Johnson

September 17, 2022

Presentation TCT 2022

Case #2: MVD With Low Ejection Fraction (High-Risk for CABG)

Presenter: Arnold Seto

September 17, 2022

Presentation TCT 2022

Case #1: Multivessel Coronary Artery Disease

Presenter: Aakriti Gupta

September 17, 2022

Advertisement

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

TCT 400: Mortality Trends in Acute Myocardial Infarction With Chronic Ischemic Heart Disease: CDC WONDER Data Analysis, 1999–2020

TCT 296: 25-Year Trends in Postoperative Mortality in U.S. Adults with Ischemic Heart Disease

TCT 573: The Impact of Hypertension on the Burden of Ischemic Heart Disease in the United States: Temporal Analysis of the Past 3 Decades

TCT 792: First-in-human experience with a novel self-expandable coronary sinus reducer for treating symptomatic epicardial and microvascular ischemic heart disease

TTVR Remains Safe, Effective in Presence of CIED Leads

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

TCT 102: First-in-Man Experience With the Self-Expandable A-Flux Coronary Sinus Reducer for Treating Symptomatic Ischemic Heart Disease

The Transformation of Diagnosis and Risk Profiling for Ischemic Heart disease: An AI Case Study

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

TCT 250: Temporal Trends in Ischemic Heart Disease-related Mortality in Canada Over the Past 3 Decades

Final Results of the Novel Healing-Targeted DES With Synchronized Antiproliferative Drug Delivery to Target Smooth Muscle Cell Proliferation After DES Implantation in Coronary Artery Disease: 5-Year Results of the PIONEER III Trial

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

TCT 615: Incorporation of Automated Robotic Transcranial Doppler to Screen for PFO and Quantify Right to Left Shunt Severity in the Evaluation of Ischemic Stroke Patients for Stroke Etiology at a Comprehensive Stroke Center

TCT 329: Cerebral Embolic Protection Devices For Prevention Of Post-Procedural Ischemic Stroke With Transcatheter Aortic Valve Replacement: A SYSTEMATIC REVIEW AND META-ANALYSIS

Case #3: Symptomatic Microvascular Disease

Case #2: MVD With Low Ejection Fraction (High-Risk for CABG)

Case #1: Multivessel Coronary Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content